摘要
目的:建立HPLC同时测定陈香露白露片中甘草苷、芸香柚皮苷和橙皮苷含量的方法,以提高陈香露白露片的质量标准。方法:采用Phenomenex Gemini C18柱(4.6 mm×250 mm, 5μm),以乙腈-0.2%乙酸(19:81)为流动相,检测波长277 nm,体积流量为1 mL·min-1,柱温30℃。结果:甘草苷、芸香柚皮苷和橙皮苷线性范围分别为0.025 6~0.818 2μg (r=0.999 6),0.026 4~0.8448μg (r=0.9995),0.1275~4.0788μg (r=0.9996);平均回收率分别为97.78%(RSD1.58%),97.65%(RSD1.31%),98.01%(RSD 1.17%)。结论:建立的陈香露白露片含量测定方法操作简便,准确度高,提高了产品检验的工作效率,可有效控制产品质量。
OBJECTIVE To improve the quality standard of Chenxiang Lubailu tablets, detect. the contents of liquiritin,narirutin and hesperidin in the prescription simultaneously by HPLC. METHODS Phenomenex Gemini C18(4.6 mm × 250 mm, 5 μm) column was used, with the mobile phase consisting of acetonitrile and 0.2% acetic acid(19:81), the DAD-3000 detection wavelength set at 277 nm, the flow rate at 1 mL·min-1, and the column temperature at 30 ℃. RESULTSUnder the chromatographic conditions, the linear ranges of liquiritin, narirutin and hesperidin were 0.025 6-0.818 2 μg(r= 0.999 6), 0.026 4-0.844 8 μg(r = 0.999 5) and 0.127 5-4.078 8 μg(r = 0.999 6), respectively. The average recoveries were 97.78%(RSD 1.58%), 97.65%(RSD 1.31%) and 98.01%(RSD 1.17%), respectively. CONCLUSION The detection method for the components in the Chenxiang Lubailu tablets is simple, accurate, and can improve the work efficiency and,effectively control the product quality.
引文
[1] Drug standard of ministry of public health of the peoples republic of China. Chinese medicine prescription preparation volume eight(中华人民共和国卫生部药品标准.中药成方制剂第八册)[S]. 1993:87-88.
[2] Zhou J, Li JL, Fu YH, et al. Quality control study on Chinese medicine composition of Chenxiang Lubailu tablets[J]. Chin Hosp Pharm J(中国医院药学杂志),2006, 26(10):1314-1316.
[3] Tong K, Ma J,Sun H, et al. Quality standard for Chenxianglubailu tablet[J]. Cent South Pharm(中南药学),2012, 10(9):644-648.
[4] Peng ZX, Zhang YJ, Xiong RY. Determination of glycyrrhetic acid in Chenxianglubailu tablets by HPLC[J].Mod Chin Med(中国现代中药),2007, 9(9):18-20.
[5] Li YF, Li ZH, Zhu ZH. HPLC determination of glycyrrhizic acid in Chenxianglubailu tablets[J]. Chin J Pharm Anal(药物分析杂志),2008, 28(2):304-305.
[6] Zhang BX, Zhou FQ, Guo QM. Research progress of flavonoids on Lonicerae japonicae Flos in last five years[J].Chin J Exp Tradit Med Form(中国实验方剂学杂志),2012,18(23):349-352.
[7] Zhan TX, Pan H, Xie H, et al. The treatment and its mechanism of hesperidin on the ulcerative colitis in rats[J]. Acta Acad Med Weifang(潍坊医学院学报),2011,33(2):160.
[8] Funaguchi N, Ohno Y, La BL, et al. Narirutin inhibits airway inflammation in an allergic mouse model[J]. Clin Exp Pharmacol Physiol, 2007, 34(8):766-770.
[9] Ha SK, Park HY, Eom H, et al. Narirutin fraction from citrus peels attenuates LPS-stimulated inflammatory response through inhibition of NF-KB and MAPKs activation[J]. Food Chem Toxicol, 2012, 50(10):3498-3504.
[10] Li RWS, Leung GPH. Vasodilatory effect of narirutin in rat mesenteric arteries and aortae[J]. J Vase Res, 2013, 50(2):37.
[11] Chakraborty S, Basu S. Multi-functional activities of citrus flavonoid narirutin in Alzheimer's disease therapeutics:An integrated screening approach and in vitro validation[J]. Int J Biol Macromol, 2017, 103:733-743.
[12] Park HY, Ha SK, Eom H, et al. Narirutin fraction from citrus peels attenuates alcoholic liver disease in mice[J].Food Chem Toxicol, 2013, 55(3):637-644.
[13] Tan SS, Chen HF, Luo XQ, et al. Effects of the narirutin combined with hesperidin in Fructus Aurantii on small intestinal propulsion function of mice[J]. J Jiangxi Univ Tradit Chin Med(江西中医药大学学报),2017, 29(4):73-75.
[14] Li CS,Pan SY. The application of liquiritin in pharmaceutical industry:China, 200610016770.O[P]. 2007-09-12.
[15]中国药典.一部(Ch. P. VolⅠ)[S]. 2015:191.